Mario Salmona

Mario Negri Institute for Pharmacological Research — Italy

Medicine · Health Sciences

75h-index21.8kcitations580works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(140), Prion Diseases and Protein Misfolding(109), Neurological diseases and metabolism(43), Trace Elements in Health(42), Cholinesterase and Neurodegenerative Diseases(37)

Publications579 total

Corrigendum to ‘Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease’ J Control Release. 2021 Feb 10;330:587–598
Journal of Controlled Release·2025
Tau catalyzes amyloid-β aggregation in a fold-dependent manner
2025Open Access
Corrigendum to “Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease” [Pharmacol. Res. 194 (2023) 106823]
Pharmacological Research·2025Open Access
Modeling immunoglobulin light chain amyloidosis in <i>Caenorhabditis elegans</i>
Disease Models & Mechanisms·2025· 1 citedOpen Access
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
Cell Death and Disease·2025· 10 citedOpen Access
THE SAGA OF THE PEPTIDE Aβ1-6A2V(D)
Istituto Lombardo - Accademia di Scienze e Lettere - Rendiconti di Scienze·2025Open Access
The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer’s disease and primary tauopathies
Pharmacological Research·2024· 1 citedOpen Access
Lysine deacetylation inhibition reverses TDP-43 mislocalization and in combination with arimoclomol ameliorates neuromuscular pathology
2024· 1 citedOpen Access
Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans
2024Open Access
Modeling immunoglobulin light chain amyloidosis in <i>Caenorhabditis elegans</i>
2024Open Access
Genetic deletion of astrocytic calcineurin <scp>B1</scp> prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease
Glia·2024· 2 cited
A cutting-edge approach based on UHPLC-MS to simultaneously investigate oxysterols and cholesterol precursors in biological samples: Validation in Huntington's disease mouse model
Talanta Open·2023Open Access
A tetracationic porphyrin with dual anti-prion activity
iScience·2023· 1 citedOpen Access
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2
EMBO Molecular Medicine·2023· 25 citedOpen Access
A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection
International Journal of Molecular Sciences·2023· 4 citedOpen Access
A tetracationic porphyrin with dual anti-prion activity
iScience·2023· 11 citedOpen Access
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
Pharmacological Research·2023· 18 citedOpen Access
Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury
Molecular Psychiatry·2023· 16 citedOpen Access
Effect of Non-Nutritive Sweeteners on the Gut Microbiota
Nutrients·2023· 60 citedOpen Access
Variations in Biodistribution and Acute Response of Differently Shaped Titania Nanoparticles in Healthy Rodents
Nanomaterials·2023· 2 citedOpen Access
page 1 of 29Next →

Frequent Co-authors

Gianluigi Forloni(19), Fabrizio Tagliavini(17), Luisa Diomede(13), Laura Colombo(10), Orso Bugiani(9), Marco Gobbi(7), Nadia Angeretti(5), Marten Beeg(5), Giacomina Rossi(5), Luca De Gioia(5), Alberto Mantovani(5), Elena Ghibaudi(5), Giorgio Giaccone(5), Roberto Chiesa(4), Valentina Bonetto(4), Elisabetta Gianazza(4), Antonio Bastone(4), Margherita Romeo(4), Mara Canovi(4), Ada De Luigi(4)